Royalty Pharma Plc (RPRX) — Cash Flow Reinvestment Rate
Royalty Pharma Plc (RPRX) has a Cash Flow Reinvestment Rate of 0.62x as of March 2026, reinvesting $470.17 Million (capex $0.00 plus investments $-470.17 Million) from operating cash flow of $760.54 Million. Check Royalty Pharma Plc (RPRX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Royalty Pharma Plc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Royalty Pharma Plc across 11 annual periods. Explore Royalty Pharma Plc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Royalty Pharma Plc (2002–2025)
Year-by-year capital reinvestment analysis for Royalty Pharma Plc. For live market cap and broader valuation context, see RPRX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | $1.36 Billion | $2.49 Billion | $0.00 | ▼ -43.3% |
| 2024 | 0.97x | $2.68 Billion | $2.77 Billion | $0.00 | ▲ +4.2% |
| 2023 | 0.93x | $2.77 Billion | $2.99 Billion | $2.12 Billion | ▼ -37.7% |
| 2022 | 1.49x | $3.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +64.0% |
| 2021 | 0.91x | $1.83 Billion | $2.02 Billion | $523.00K | ▼ -65.1% |
| 2020 | 2.60x | $5.29 Billion | $2.03 Billion | $2.20 Billion | ▲ +13.0% |
| 2019 | 2.30x | $3.84 Billion | $1.67 Billion | $1.72 Billion | ▲ +342.1% |
| 2018 | 0.52x | $842.61 Million | $1.62 Billion | $269.59 Million | ▼ -74.3% |
| 2017 | 2.03x | $2.88 Billion | $1.42 Billion | $2.29 Billion | — |
| 2003 | 0.00x | $0.00 | $11.15 Million | $0.00 | ▼ -100.0% |
| 2002 | 0.01x | $49.00K | $8.45 Million | $49.00K | — |